These results suggested that Tim-3 blockade might not only increase the infiltration of CD8+ TILs in the TME and enhance the cytotoxicity of specific antitumor CD8+ T lymphocytes but also decrease the levels of tumor-promoting cytokines. This evidence concerns the gene CD8A and neoplasm.